Carlsmed, Inc. ( CARL) - Key Metrics
CARL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.70 | -$0.39 | -$0.27 | -$0.28 |
| 2026Q1 | $0.60 | -$0.32 | -$0.48 | -$0.49 |
| 2025Q4 | $1.07 | -$0.61 | -$0.37 | -$0.34 |
| 2025Q3 | $0.62 | -$0.40 | -$0.40 | -$0.42 |
| 2025Q2 | $2.63 | -$1.47 | -$1.53 | -$1.65 |
CARL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -6.65 |
| 2026Q1 | 0% | -7.07 |
| 2025Q4 | 0% | -12.35 |
| 2025Q3 | 0% | -8.37 |
| 2025Q2 | 0% | -2.47 |
CARL
Price: $14.73
52 week price:
Earnings Per Share: -2.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Health Information Services
Market Capitalization: 424.1 million